ADC Therapeutics SA is a clinical-stage biotechnology company, which develops antibody drug conjugates. Its products include Lonca, Cami and ADCT-602. Its drugs are used in treating various advanced solid tumors. The company was founded on June 6, 2011 and is headquartered in Epalinges, Switzerland.
$1.92 -0.06 (-3.03%)
As of 03/24/2023 15:59:39 EST IEX book CBOE book
2022 © Stock Market MBA, Inc.